AU2003262091A1 - Novel dipeptide compound and medical use tehreof - Google Patents

Novel dipeptide compound and medical use tehreof

Info

Publication number
AU2003262091A1
AU2003262091A1 AU2003262091A AU2003262091A AU2003262091A1 AU 2003262091 A1 AU2003262091 A1 AU 2003262091A1 AU 2003262091 A AU2003262091 A AU 2003262091A AU 2003262091 A AU2003262091 A AU 2003262091A AU 2003262091 A1 AU2003262091 A1 AU 2003262091A1
Authority
AU
Australia
Prior art keywords
tehreof
medical use
dipeptide compound
novel dipeptide
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003262091A
Other languages
English (en)
Inventor
Tsutomu Mimoto
Keisuke Terashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2003262091A1 publication Critical patent/AU2003262091A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AU2003262091A 2002-09-13 2003-09-11 Novel dipeptide compound and medical use tehreof Abandoned AU2003262091A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002269031A JP2006076882A (ja) 2002-09-13 2002-09-13 新規なジペプチド化合物及びその医薬用途
JP2002-269031 2002-09-13
PCT/JP2003/011672 WO2004024685A1 (fr) 2002-09-13 2003-09-11 Nouveaux composes dipeptidiques et utilisation de ces derniers a des fins medicales

Publications (1)

Publication Number Publication Date
AU2003262091A1 true AU2003262091A1 (en) 2004-04-30

Family

ID=31986803

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003262091A Abandoned AU2003262091A1 (en) 2002-09-13 2003-09-11 Novel dipeptide compound and medical use tehreof

Country Status (3)

Country Link
JP (1) JP2006076882A (fr)
AU (1) AU2003262091A1 (fr)
WO (1) WO2004024685A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ514017A (en) * 1999-12-28 2003-10-31 Japan Energy Corp Novel dipeptide compound and medicinal use thereof
HN2002000136A (es) * 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis

Also Published As

Publication number Publication date
JP2006076882A (ja) 2006-03-23
WO2004024685A1 (fr) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003231752A1 (en) Tack and tack applier
IL201111A0 (en) Ester compound and medical use thereof
AU2003214945A1 (en) Multi-function catheter and use thereof
AU2003228445A1 (en) Tissue composites and uses thereof
AU2003226094A1 (en) Compounds and methods
AU2003254844A1 (en) Substituted amino compounds and use thereof
AU2003246083A1 (en) Ferrocene compound and use thereof
AU2003257577A1 (en) Sponge prophy
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003277671A1 (en) Gasket and syringe
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003220931A1 (en) 2-pyrone compounds and use thereof
AU2003262091A1 (en) Novel dipeptide compound and medical use tehreof
AU2003292774A1 (en) Novel proteins and use thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2003216442A1 (en) Enkurin and uses thereof
AU2003242790A1 (en) Therapeutic compound against leishmania infection and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase